相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection
Yuying Luo et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades
Annick Moens et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study
Hsu-Heng Yen et al.
INTESTINAL RESEARCH (2019)
Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection
Clayton M. Spiceland et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality
Mona Rezapour et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting
Patricia Guedes Garcia et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies
Tuo Chen et al.
JOURNAL OF CROHNS & COLITIS (2018)
Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
Maria J. G. T. Vehreschild et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE)
Christoph Hoegenauer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection
Minghuan Jiang et al.
PLOS ONE (2018)
Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infection in Patients With and Without Inflammatory Bowel Disease: A Tertiary Care Center's Experience
Obada M. Tabbaa et al.
GASTROENTEROLOGY RESEARCH (2018)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Changes in microbial ecology after fecal microbiota transplantation for recurrent C-difficile infection affected by underlying inflammatory bowel disease
Sahil Khanna et al.
MICROBIOME (2017)
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France
Emilie Baro et al.
PLOS ONE (2017)
Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease
Krista M. Newman et al.
GUT MICROBES (2017)
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
Alireza Meighani et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014
Jeffery Ho et al.
EMERGING INFECTIOUS DISEASES (2017)
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience
Samantha M. Chin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem
Matthew T. Brady et al.
DISEASES OF THE COLON & RECTUM (2017)
Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute
Sahil Khanna et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study
Monika Fischer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study
Roshan Razik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Alexander Khoruts et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2016)
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
Monika Fischer et al.
INFLAMMATORY BOWEL DISEASES (2016)
Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients
Colleen R. Kelly et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease
Henry A. Horton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Factors Associated With Readmissions and Outcomes of Patients Hospitalized for Inflammatory Bowel Disease
Geoffrey C. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab
Fernando S. Velayos et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
Matthew J. Hamilton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Cost-Effectiveness of Early Colectomy With Ileal Pouch-Anal Anastamosis Versus Standard Medical Therapy in Severe Ulcerative Colitis
K. T. Park et al.
ANNALS OF SURGERY (2012)
The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital
Alan J. Forster et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Burden of Gastrointestinal Disease in the United States: 2012 Update
Anne F. Peery et al.
GASTROENTEROLOGY (2012)
Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis
Udayakumar Navaneethan et al.
JOURNAL OF CROHNS & COLITIS (2012)
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease
M-H. Jen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Strategies for the Prevention of Postoperative Recurrence in Crohn's Disease: Results of a Decision Analysis
Ashwin N. Ananthakrishnan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Impact of Clostridium difficile infection in patients with ulcerative colitis
Revital Kariv et al.
JOURNAL OF CROHNS & COLITIS (2011)
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients
Geoffrey C. Nguyen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Cost effectiveness of adult intensive care in the UK
S. Ridley et al.
ANAESTHESIA (2007)
Impact of Clostridium difficile on inflammatory bowel disease
Mazen Issa et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)